SpiroTact® and VIPER technology: a promising rapid point-of-care test for active syphilis
Preprint
- 9 February 2026
- preprint
- Published by F1000 Research Ltd in VeriXiv
Abstract
No abstract availableAll Related Versions
Funding Information
- Bill and Melinda Gates Foundation (INV-077047)
This publication has 8 references indexed in Scilit:
- Barriers and facilitators to HIV and syphilis rapid diagnostic testing in antenatal care settings in low-income and middle-income countries: a systematic reviewBMJ Global Health, 2022
- Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016Bulletin of the World Health Organization, 2019
- Adult gonorrhea, chlamydia and syphilis prevalence, incidence, treatment and syndromic case reporting in South Africa: Estimates using the Spectrum-STI model, 1990-2017PLOS ONE, 2018
- Shortages of benzathine penicillin for prevention of mother-to-child transmission of syphilis: An evaluation from multi-country surveys and stakeholder interviewsPLOS Medicine, 2017
- Increase in Incidence of Congenital Syphilis — United States, 2012–2014MMWR. Morbidity and Mortality Weekly Report, 2015
- Comparison of Diagnostic Accuracy of PCR Targeting the 47-Kilodalton Protein Membrane Gene of Treponema pallidum and PCR Targeting the DNA Polymerase I Gene: Systematic Review and Meta-analysisJournal of Clinical Microbiology, 2015
- Serologic Testing for Syphilis: Benefits and Challenges of a Reverse AlgorithmClinical Microbiology Newsletter, 2014
- Point-of-care tests for diagnosing infections in the developing worldClinical Microbiology and Infection, 2010